Dopaminergic therapy in children with restless legs/periodic limb movements in sleep and ADHD. Dopaminergic Therapy Study Group. (Q48726305)

15 February 2018

title

Dopaminergic therapy in children with restless legs/periodic limb movements in sleep and ADHD. Dopaminergic Therapy Study Group. (English)

1 reference

15 February 2018

1 reference

Walters AS

1

1 reference

15 February 2018

Mandelbaum DE

2

1 reference

15 February 2018

Lewin DS

3

1 reference

15 February 2018

Kugler S

4

1 reference

15 February 2018

England SJ

5

1 reference

15 February 2018

Miller M

6

1 reference

15 February 2018

publication date

1 March 2000

1 reference

15 February 2018

published in

Pediatric Neurology

1 reference

15 February 2018

volume

22

1 reference

15 February 2018

page(s)

182-186

1 reference

15 February 2018

issue

3

1 reference

15 February 2018

Toward a better definition of the restless legs syndrome. The International Restless Legs Syndrome Study Group

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0887-8994%2899%2900152-6

7 January 2021

Clinical, polysomnographic, and genetic characteristics of restless legs syndrome: a study of 133 patients diagnosed with new standard criteria.

1 reference

https://api.crossref.org/works/10.1016%2FS0887-8994%2899%2900152-6

7 January 2021

Restless legs syndrome in childhood and adolescence

1 reference

https://api.crossref.org/works/10.1016%2FS0887-8994%2899%2900152-6

7 January 2021

Moderate to severe periodic limb movement disorder in childhood and adolescence.

1 reference

https://api.crossref.org/works/10.1016%2FS0887-8994%2899%2900152-6

7 January 2021

Periodic limb movement disorder and restless legs syndrome in children with attention-deficit hyperactivity disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0887-8994%2899%2900152-6

7 January 2021

Further studies on periodic limb movement disorder and restless legs syndrome in children with attention-deficit hyperactivity disorder.

1 reference

https://api.crossref.org/works/10.1016%2FS0887-8994%2899%2900152-6

7 January 2021

Signs of Airway Obstruction During Sleep and Behavioral, Developmental, and Academic Problems

1 reference

https://api.crossref.org/works/10.1016%2FS0887-8994%2899%2900152-6

7 January 2021

Children and nocturnal snoring: evaluation of the effects of sleep related respiratory resistive load and daytime functioning

1 reference

https://api.crossref.org/works/10.1016%2FS0887-8994%2899%2900152-6

7 January 2021

Attention deficit hyperactivity disorder: the differential diagnosis

1 reference

https://api.crossref.org/works/10.1016%2FS0887-8994%2899%2900152-6

7 January 2021

The myth of attention deficit-hyperactivity disorder: symptoms resulting from multiple causes

1 reference

https://api.crossref.org/works/10.1016%2FS0887-8994%2899%2900152-6

7 January 2021

Sleep-disordered breathing and school performance in children

1 reference

https://api.crossref.org/works/10.1016%2FS0887-8994%2899%2900152-6

7 January 2021

Symptoms of sleep disorders, inattention, and hyperactivity in children.

1 reference

https://api.crossref.org/works/10.1016%2FS0887-8994%2899%2900152-6

7 January 2021

Attention deficit hyperactivity disorder: a disease or a symptom complex?

1 reference

https://api.crossref.org/works/10.1016%2FS0887-8994%2899%2900152-6

7 January 2021

Comorbidity: a critical issue in attention deficit disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0887-8994%2899%2900152-6

7 January 2021

Treatment of restless legs syndrome and periodic movements during sleep with L-dopa: a double-blind, controlled study

1 reference

https://api.crossref.org/works/10.1016%2FS0887-8994%2899%2900152-6

7 January 2021

L-dopa therapy of uremic and idiopathic restless legs syndrome: a double-blind, crossover trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0887-8994%2899%2900152-6

7 January 2021

A double-blind randomized crossover trial of bromocriptine and placebo in restless legs syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS0887-8994%2899%2900152-6

7 January 2021

Randomized, double-blind, placebo-controlled trial of pergolide in restless legs syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS0887-8994%2899%2900152-6

7 January 2021

Pergolide in the management of restless legs syndrome: an extended study

1 reference

https://api.crossref.org/works/10.1016%2FS0887-8994%2899%2900152-6

7 January 2021

Effect of pramipexole in treatment of resistant restless legs syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS0887-8994%2899%2900152-6

7 January 2021

Encouraging initial response of restless legs syndrome to pramipexole.

1 reference

https://api.crossref.org/works/10.1016%2FS0887-8994%2899%2900152-6

7 January 2021

Ropinirole for restless legs syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0887-8994%2899%2900152-6

7 January 2021

Normative data on revised Conners Parent and Teacher Rating Scales

1 reference

https://api.crossref.org/works/10.1016%2FS0887-8994%2899%2900152-6

7 January 2021

Developmental normative data on the test of variables of attention (T.O.V.A.).

1 reference

https://api.crossref.org/works/10.1016%2FS0887-8994%2899%2900152-6

7 January 2021

Neurotransmitter transporters: recent progress

1 reference

https://api.crossref.org/works/10.1016%2FS0887-8994%2899%2900152-6

7 January 2021

Association and linkage of the dopamine transporter gene and attention-deficit hyperactivity disorder in children: heterogeneity owing to diagnostic subtype and severity

1 reference

https://api.crossref.org/works/10.1016%2FS0887-8994%2899%2900152-6

7 January 2021

An open clinical trial of L-dopa and carbidopa in adults with minimal brain dysfunction

1 reference

https://api.crossref.org/works/10.1016%2FS0887-8994%2899%2900152-6

7 January 2021

Behavioral effects of carbidopa/levodopa in hyperactive boys

1 reference

https://api.crossref.org/works/10.1016%2FS0887-8994%2899%2900152-6

7 January 2021

Effects of levodopa on attention deficit disorder, residual type

1 reference

https://api.crossref.org/works/10.1016%2FS0887-8994%2899%2900152-6

7 January 2021

D1- versus D2-receptor modulation of visuospatial working memory in humans.

1 reference

https://api.crossref.org/works/10.1016%2FS0887-8994%2899%2900152-6

7 January 2021

10.1016/S0887-8994(99)00152-6

Identifiers

DOI

1 reference

15 February 2018

PubMed ID

10734247

1 reference

15 February 2018